PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter OutlookBusiness Wire • 10/17/22
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in GhanaBusiness Wire • 10/13/22
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and ManufacturingBusiness Wire • 09/26/22
PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis DetectionBusiness Wire • 09/22/22
PerkinElmer, Inc. (PKI) Presents at Baird's 2022 Global Healthcare Conference (Transcript)Seeking Alpha • 09/15/22
PerkinElmer (PKI) Down 11.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 08/31/22
Parkland Corporation's (PKIUF) CEO Bob Espey on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/05/22
PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/05/22
New Mountain Capital Announces Intent to Acquire PerkinElmer's Applied, Food and Enterprise Services Businesses for up to $2.45 BillionBusiness Wire • 08/01/22
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics CompanyBusiness Wire • 08/01/22
Earnings Preview: PerkinElmer (PKI) Q2 Earnings Expected to DeclineZacks Investment Research • 07/28/22